Skip to main content
. 2015 Oct 6;30(6):869–874. doi: 10.1007/s10877-015-9787-3

Table 3.

Hemodynamic variables and ETCO2

Sevoflurane
(n = 14)
Propofol
(n = 14)
P
mBP (mmHg)
 T1: control 87 ± 9 87 ± 21 0.74
 T2: intubation 75 ± 13 70 ± 12 0.42
 T3: lateral 79 ± 17 71 ± 14 0.16
 T4: lateral 1 h 76 ± 12 78 ± 13 0.68
 T5: supine 82 ± 13 79 ± 17 0.63
Heart rate (bpm)
 T1 75 ± 23 72 ± 13 0.64
 T2 68 ± 22 71 ± 14 0.61
 T3 67 ± 17 71 ± 14 0.52
 T4 72 ± 14 77 ± 11 0.43
 T5 73 ± 15 75 ± 11 0.68
ETCO2 (mmHg)
 T1 27 ± 6 31 ± 6 0.07
 T2 32 ± 6 34 ± 6 0.26
 T3 36 ± 3 32 ± 6 0.07
 T4 34 ± 5 34 ± 6 0.81
 T5 34 ± 6 34 ± 6 0.87

Data are shown as mean ± SD. There was no difference in mBP, heart rate and ETCO2 between the sevoflurane and propofol groups at any time point